Depression and Anxiety Trial, By Invitation NCT07398040 Sponsor: Universidad de Zaragoza Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, By Invitation

NCT07398040
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older.
  • People who have mild, moderate, or severe symptoms of anxiety, depression, or stress, as measured by a questionnaire called the DASS-42.
  • People who do not have any medical reasons that would prevent them from following a personalised diet.
  • People who do not have cognitive impairment (problems with thinking or memory).
  • People who speak and understand Spanish fluently.
  • People who are available over a 4-month period to attend scheduled appointments and sessions.
  • People who currently have low or moderate adherence to the Mediterranean diet, based on a specific questionnaire (a score of 9 or below out of 14).
  • People who will be living in the city of Zaragoza for the entire duration of the study.
  • People who have signed a consent form after being given detailed information about the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose DASS-42 scores show either extremely severe symptoms (the kind that would need urgent clinical care) or scores in the normal range.
  • People who have physical health conditions that would prevent them from following the dietary part of the study, or that would significantly interfere with taking part.
  • People who are unable to attend the required in-person sessions.
  • People who have been diagnosed with, or are suspected of having, an unstable medical condition or a physical illness that is currently causing severe physical or mental distress (for example, an active flare-up of inflammatory bowel disease).
  • People who are pregnant.
  • People who are currently taking part in another programme specifically focused on diet or exercise.
  • People who have a diagnosis of a severe psychiatric disorder, such as bipolar disorder type I or II, or a personality disorder as their primary diagnosis.
  • People who currently have a substance use disorder.
  • People who have a medical diagnosis that could explain or mask mental health symptoms, such as an uncontrolled hormonal condition like thyroid dysfunction.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Universidad de Zaragoza
Registry
ClinicalTrials.gov
Start date
16 January 2026
Est. completion
28 February 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Anxiety level (Depression, Anxiety, Stress Scale; DASS-42); Depression level (Depression, Anxiety, Stress Scale; DASS-42); SF-36; GLUCEMIC PROFILE; INFLAMMATORY PROFILE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov